Two Years’ Persistence of Naturally Present Substitution R155K Within Hepatitis C Virus NS3 Protease in the Absence of Protease Inhibitor

Two Years’ Persistence of Naturally Present Substitution R155K Within Hepatitis C Virus NS3 Protease in the Absence of Protease Inhibitor–based Therapy

Published:2011-05-01 Issue:9 Volume:203 Page:1341-1342
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Colson Philippe,Gérolami René

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/203/9/1341/18064927/jir021.pdf

Reference12 articles.

1. Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individual;Kim;J Infect Dis,2009

2. Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naïve chronically infected patient;Colson;Hepatology,2008

3. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects;Bartels;J Infect Dis,2008

4. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients;Kuntzen;Hepatology,2008

5. Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy;Morsica;J Acquir Immune Defic Syndr,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome;Viruses;2020-02-28

2. HCV Drug Resistance;Antimicrobial Drug Resistance;2017

3. Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: Novel insights about targeted genotyping approaches;Journal of Medical Virology;2014-07-11

4. Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus;Journal of Antimicrobial Chemotherapy;2013-02-06

5. Natural presence of NS3 protease R155K hepatitis C virus variants with decreased sensitivity to protease inhibitors;Journal of Clinical Virology;2012-02